Company Profile (AI Text)
Name: Pirouette Pharma (YC S21)
Canonical URL: https://wefunder.com/pirouette
Updated at: 2026-06-03T16:03:34Z

Tagline: Reengineering life-saving injections; #1 most raised campaign in Wefunder history

Key claims:
- Total raised on Wefunder: 12755159 | citation: https://wefunder.com/pirouette#claim-total-raised
- Total investors: 4910 | citation: https://wefunder.com/pirouette#claim-total-investors

Verified facts:
- Total raised on Wefunder: 12755159 | observed_at: 2026-06-03T16:03:34Z | expires_at: 2026-06-04T16:03:34Z
- Total investors: 4910 | observed_at: 2026-06-03T16:03:34Z | expires_at: 2026-06-04T16:03:34Z

Computed metrics:
- total_amount_raised: 12755159
- total_investors: 4910
- team_size: 10
- featured_investor_count: 10
- faq_count: 5
- recent_post_count: 0

Quick facts:
- #1 Wefunder raise in history ($7.8M; 4000+ investors) + backed by top life sciences VCs | citation: https://wefunder.com/pirouette#claim-fact-1
- $800M+ in licensing deal potential with 4 medications targeting FDA approval in 2027, 2028, and 2029 | citation: https://wefunder.com/pirouette#claim-fact-2
- Big pharma + an aerospace leader are in advanced talks to use OnePush across multiple medicines | citation: https://wefunder.com/pirouette#claim-fact-3
- 23 granted patents globally with more pending; clear path to commercialize worldwide by 2027 | citation: https://wefunder.com/pirouette#claim-fact-4
- 100% of oncologists would prescribe OnePush over current auto-injectors in blinded research study | citation: https://wefunder.com/pirouette#claim-fact-5
- OnePush targets a $1T dollar injectable market as self‑care shifts to simpler at‑home devices | citation: https://wefunder.com/pirouette#claim-fact-6
- Type C Meeting with FDA gave a defined path for an OTC approval—a validation of its ease of use! | citation: https://wefunder.com/pirouette#claim-fact-7
- $600M+ projected in annual sales by year 5 (not guaranteed) | citation: https://wefunder.com/pirouette#claim-fact-8

Investor memos:
- Safar Partners: https://uploads.wefunder.com/uploads/remote_files/831622-SbCdhn0WjfMdhoJ8OA0m3wtA/Pirouette_Safar_Partners_Investment_Memo_20240515.pdf | citation: https://wefunder.com/pirouette#claim-investor-memo-1
- Kingscrowd Capital: https://kingscrowd.com/pirouette-medical-on-wefunder-2024/ | citation: https://wefunder.com/pirouette#claim-investor-memo-2

FAQ:
- Q: How do investors at this stage get a ROI? What are the trigger events to convert investment money into shares later on?
  A: Great question! You can learn more about the ROI here: https://help.wefunder.com/#/investor/after-you-invest The triggering event for the SAFE to convert to shares is the next "Qualified Financing" as described here: "In the event that the Company issues and sells Preferred Stock in a bona fide transaction or series of transactions with the principal purpose of raising capital for aggregate proceeds of at least US$10,000,000 at a fixed valuation, including but not limited to, a pre-money or p...
- Q: Conor, Few questions. 1. Regarding the narcan, your competition would be not just from other autoinjection products but intranasal products. Even if your autojectable narcan is the best and cheapest on the market how do you compete against intranasal narcan and did any of your...
  A: Hi David - these are all great questions! “I lost a couple nephews and a niece, and I'm convinced a device like this could have saved them.” -Opioid Dependent User “I absolutely loved the device. The stick function [adhesive base] is great. What you pointed out about nasal sprays, how patient orientation matters, you’ve done a lot of research, I didn’t even think about that and how the drug can dribble down the patient’s face.” -Legislative Assistant (Healthcare) at the U.S. House of Represen...
- Q: Are they recyclable maybe even re-usable? Or just one time use and trash? Sorry if you already put that info in the info and I missed it.
  A: Hi Mical, thanks for the question! At this time the devices are based off of our first generation auto-injector platform and are single-use, disposable systems. The single-use nature aims to make the device intuitive to use and reduce complexity. In the future, we foresee a potential for a next generation version that could be multi-use.
- Q: Hello Conor, I made an investment, but considering upping it depending upon what I learn from the answers to my questions. - Is there a standard for vial that you are building the platform to? size/format etc. - If yes, what is the friction in introducing new drugs with your p...
  A: Hi Prakash, thanks for the fantastic questions. The short answer is YES! We use the pharma standards as much as possible to make it simple for partners to pair their drug with our device. The container closure system is a standard type I glass of common ID/OD, and sits in a standard nest/tub configuration for compatibility with the standard fill/finish process. We can operate either way, receiving the drug product and completing all kitting or licensing the device to the partner if they want ...
- Q: What is the price of each share of Pirouette Medical Devices on wefunder.com!@
  A: Hello! The vehicle is a SAFE which converts to equity at the next priced round. Check out https://help.wefunder.com/#/glossary/contract for more information.